Altamira Therapeutics Ltd. (CYTOF): SCHEDULE 13D/A filed May 6, 2025

Form type

SCHEDULE 13D/A

Filing date

May 6, 2025

Accession number

0001213900-25-039888

Filer

Altamira Therapeutics Ltd. (CIK 1601936)